Upcoming moves by the FDA could spur a number of pharmacogenomic studies for warfarin and eventually bring pharmacogenomic tests into the mainstream. The Food and Drug Administration is considering changes to the label of warfarin, a popular anticoagulant, that warn consumers of the drug’s varying effects on people depending on their genotypes. While there are […]